- •Surfaces in ICU environments are frequently contaminated by microbial pathogens.
- •ICU common area surfaces had higher bacterial burden than those in patient's rooms.
- •ATP bioluminescence can provide rapid feedback on ICU surface cleanliness.
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to American Journal of Infection Control
- Changes in prevalence of health care-associated infections in U.S. hospitals.N Engl J Med. 2018; 379: 1732-1744
- Prior environmental contamination increases the risk of acquisition of vancomycin-resistant enterococci.Clin Infect Dis. 2008; 46: 678-685
- Risk of acquiring multidrug-resistant gram-negative bacilli from prior room occupants in the intensive care unit.Clin Microbiol Infect. 2011; 17: 1201-1208
- Evidence that contaminated surfaces contribute to the transmission of hospital pathogens and an overview of strategies to address contaminated surfaces in hospital settings.Am J Infect Control. 2013; 41: S6-11
- The impact of enhanced cleaning within the intensive care unit on contamination of the near-patient environment with hospital pathogens: a randomized crossover study in critical care units in two hospitals.Crit Care Med. 2011; 39: 651-658
- Intensive care unit environmental surfaces are contaminated by multidrug-resistant bacteria in biofilms: combined results of conventional culture, pyrosequencing, scanning electron microscopy, and confocal laser microscopy.J Hosp Infect. 2015; 91: 35-44
- Presence of biofilm containing viable multiresistant organisms despite terminal cleaning on clinical surfaces in an intensive care unit.J Hosp Infect. 2012; 80: 52-55
- Bedside resuscitation bags: a source of bacterial contamination.Infect Control. 1985; 6: 231-232
- Bacterial growth in secretions and on suctioning equipment of orally intubated patients: a pilot study.Am J Crit Care. 2002; 11: 141-149
- Survival of Acinetobacter baumannii on bed rails during an outbreak and during sporadic cases.J Hosp Infect. 1999; 42: 27-35
- Hospital privacy curtains are frequently and rapidly contaminated with potentially pathogenic bacteria.Am J Infect Control. 2012; 40: 904-906
- Computer keyboard and mouse as a reservoir of pathogens in an intensive care unit.J Clin Monit Comput. 2004; 18: 7-12
- Contamination of patients’ files in intensive care units: an indication of strict handwashing after entering case notes.Am J Infect Control. 2005; 33: 398-401
- Microbiological contamination of mobile phones of clinicians in intensive care units and neonatal care units in public hospitals in Kuwait.BMC Infect Dis. 2015; 15: 434
- Effectiveness of ATP bioluminescence to assess hospital cleaning: a review.J Prev Med Hyg. 2017; 58: E177-E183
- ATP bioluminescence assay for evaluating cleaning practices in operating theatres: applicability and limitations.BMC Infect Dis. 2018; 18: 583
- Examining the association between surface bioburden and frequently touched sites in intensive care.J Hosp Infect. 2017; 95: 76-80
- Computer keyboard and mouse: an intervention study on methicillin-resistant staphylococcus aureus decontamination in 4 intensive care units.J Crit Care. 2017; 37: 266-267
- Effectiveness of visual inspection compared with non-microbiologic methods to determine the thoroughness of post-discharge cleaning.Antimicrob Resist Infect Control. 2013; 2: 26
- Application of a fluorescent marker with quantitative bioburden methods to assess cleanliness.Infect Control Hosp Epidemiol. 2018; 39: 1296-1300
- The adenosine triphosphate method as a quality control tool to assess ‘cleanliness’ of frequently touched hospital surfaces.J Hosp Infect. 2015; 91: 166-170
- Monitoring the effectiveness of hospital cleaning practices by use of an adenosine triphosphate bioluminescence assay.Infect Control Hosp Epidemiol. 2009; 30: 678-684
Funding: The work was supported by an unrestricted research grant from 3M to Cleveland Clinic.
Disclosures: A.D. has received research funding from 3M and Clorox and is on the advisory board of Ferring Pharmaceuticals. C.J.D. is on the advisory board of 3M and has received research funding from Gojo, PDI, and Clorox. S.M.G. is on the advisory board of 3M. All other authors report no conflicts of interest relevant to this article.